Nuvectis Pharma, Inc. NVCT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s total current assets?
- Nuvectis Pharma, Inc. (NVCT) reported total current assets of $25.4M in Q1 2026.
- How has Nuvectis Pharma, Inc.'s total current assets changed year-over-year?
- Nuvectis Pharma, Inc.'s total current assets decreased by 15.8% year-over-year, from $30.15M to $25.4M.
- What is the long-term trend for Nuvectis Pharma, Inc.'s total current assets?
- Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s total current assets has grown at a 52.7% compound annual growth rate (CAGR), from $5.83M to $31.71M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.